Learn More
Medchemexpress LLC Gefitinib-d8 | 857091-32-8 | 98.4% | 454.95 | 1 MG

Supplier: Medchemexpress LLC 1MGHY50895S
Gefitinib-d8 (ZD1839-d8) is a deuterium-labeled Gefitinib. Gefitinib acts as an EGFR tyrosine kinase inhibitor, with an IC50 of 2-37 nM in NR6wtEGFR cells. Stable heavy isotopes of hydrogen, carbon, and other elements are incorporated into drug molecules as tracers for quantitation during drug development. Deuteration has the potential to affect the pharmacokinetic and metabolic profiles of drugs.
- Used as a tracer
- Functions as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS
- Deuteration may affect pharmacokinetic and metabolic profiles of drugs
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.